The short version
Just 2 companies supply this market — thin enough that a single exit would be felt immediately.
Market view
adalimumab-afzb · Kit
6 marketed package NDCs · 2 active manufacturers
What changed in the last 90 days
Every detected change for adalimumab-afzb, newest first — price moves, shortages, recalls, and manufacturers entering or leaving. Detected by comparing each day’s federal data against the day before.
- AbriladaAug 18, 2026New productA-S Medication Solutions
Common questions
- Is Adalimumab-afzb in shortage right now?
- No. FDA does not currently list Adalimumab-afzb in shortage. This page is rebuilt every morning from FDA's shortage database, so a new posting appears here the day it is published.
- Who makes Adalimumab-afzb?
- 2 companies have marketed Adalimumab-afzb in the last 30 days, according to the FDA NDC Directory. That is a thin market — if one stops making it, supply is at risk quickly. Every manufacturer and package is listed on this page.
Shortage reports for this molecule
- Planned discontinuation — Abrilada, Injection, Kit (NDC 0025-0325-01)Oct 9, 2025
All marketed products
Expand a strength to see its dosage forms, then package sizes, then each manufacturer and NDC. Click an NDC for its full detail page.